Work

R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9

Year: 2009

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2009.04.032

Authors: Wei Peng Yong, Tae Won Kim, Samir D. Undevia, Federico Innocenti, Mark J. Ratain

Institution: University of Chicago

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1313969261, Phase I Clinical Trials of Anti-Cancer Agents

OpenAlex ID: W1972638427

FWCI: 0.299

Cites: 20

Cited by: 4

Related to: 10